SUMMARY The in-vitro activity of rosoxacin against 173 isolates of Neisseria gonorrhoeae, including 17 P-lactamase-producers, was tested by an agar dilution method. Of the isolates, 167 (including 16 of the P-lactamase-producers) were inhibited by 0'06 mg/l of rosoxacin. The remaining six isolates, one of which produced P-lactamase and the others were moderately resistant to penicillin, were inhibited by 0' 12-0' 25 mg/l of the compound. There was little correlation between the minimum inhibitory concentrations (MICs) of rosoxacin and penicillin, except for isolates with MICs of penicillin of 0 06-1 mg/l, for which correlation was good.
Introduction
Rosoxacin (WIN 35213) is an antibacterial agent chemically related to nalidixic acid (fig 1) . Appreciable activity against Neisseria gonorrhoeae has been noted' (Sterling Winthrop, unpublished data) . In this paper we report the activity of rosoxacin against 173 isolates of N gonorrhoeae, including 17 P-lactamase-producers, and correlate this activity with that of benzylpenicillin.
Materials and methods
All the isolates of N gonorrhoeae, including the P-lactamase-producers, were from patients attending MICs of benzylpencillin and those of rosoxacin was poor (correlation coefficient r = 0 17) but was better if the P-lactamase-producers were excluded (r=0 48). When only isolates with MICs of benzylpenicillin of 0 06-1 mg/l inclusive were considered, correlation between MICs of the two agents was good (r = 0 76). The geometric mean MIC of rosoxacin for penicillin-sensitive isolates-that is those with MICs of 0 03 mg/l or less-was 0-025 mg/l; for isolates that were moderately resistant to penicillin it was 0-034 mg/l, which was aB .* significantly if only slightly higher (P 0-001 by Student's t test). The mean MIC of rosoxacin for the P-lactamase-producers was 0-024 mg/I, which was very similar to that for penicillin-sensitive isolates.
Inverse correlation between the diameter of the zone of inhibition produced by a 5-,ug disc of rosoxacin and the MIC of rosoxacin was poor (r = -0 24; fig 3) . This may reflect the narrow range of MICs of rosoxacin for gonococci. 
Discussion
From its in-vitro activity rosoxacin appears to be a promising agent against the gonococcus. However we did not find the compound to be quite so active as did other workers who reported all isolates to be inhibited by 0-05 mg/l (Sterling Winthrop, unpublished data). The sensitivity of P-lactamaseproducers to rosoxacin is not surprising since the compound is unrelated to the P-lactams. On the other hand, the good correlation between MICs of rosoxacin and benzylpenicillin for moderately penicillin-resistant gonococci suggests that their penetration barrier to penicillin is also effective to some extent against rosoxacin, as it is against some other agents.2-4 Nevertheless, the MICs of rosoxacin for these moderately penicillin-resistant isolates were well below the peak plasma concentrations of rosoxacin, which are about 6 mg/l after a single dose of 300 mg (Sterling Winthrop, unpublished data). 
